HCC	Hepatocellular carcinoma
BCLC	Barcelona-Clínic Liver Cancer
VEGF	Vascular endothelial growth factor
EpCAM	Epithelial cell adhesion molecule
AFP	Alpha-fetoprotein
WNT	Wingless-related integration site
CNV	Copy number variation
HBV	Hepatitis B Virus
HCV	Hepatitis C Virus
NAFLD	Nonalcoholic fatty liver disease
OS	Median overall survival
RFA	Radiofrequency Ablation
TACE	Transarterial chemoembolization
MET	Metabolic equivalent of task
RAF	Rapidly Accelerated Fibrosarcoma
PDGFR	Platelet-derived growth factor
PD-1	Programmed cell death protein 1
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
RET	Rearranged during transfection
AST	Aspartate aminotransferase
ALT	Alanine transaminase
FMS	Fibromyalgia syndrome
GAS6	Growth arrest-specific 6
PFS	Progression-free survival
HR	Hazard ratio
CI	Confidence interval
ORR	Overall response rate
TCGA	The Cancer Genome Atlas
KMT2D	Histone-lysine N-methyltransferase 2D
CREBBP	cAMP response element-binding protein
PI3K	Phosphatidylinasitol-3-kinase
mTOR	Mammalian target of rapamycin
PTEN	Phosphatase and tensin homolog
NFE2L2	Nuclear factor-like 2
FGF	Fibroblast growth factors
TACE	Transcatheter arterial chemoembolism
HGF	Hepatic growth factor
CDKN2A	Cyclin Dependent Kinase Inhibitor 2A
TP53	Tumor Protein 53
MLL4	Mixed Lineage Leukemia 4
ARID1A	AT-Rich Interaction Domain 1A
ARID2	AT-Rich Interaction Domain 2
TERT	Telomerase reverse transcriptase
EGFR	Epidermal growth factor receptor